One Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

One Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Hold	1,356	–	–	0.01%	492
2026 Q1	$229K	Sell	1,356 -45	-3%	-$7.7K	0.01%	492
2025 Q4	$237K	Sell	1,401 -201	-13%	-$32.6K	0.01%	481
2025 Q3	$231K	Sell	1,602 -86	-5%	-$11.7K	0.01%	451
2025 Q2	$214K	Sell	1,688 -77	-4%	-$9.45K	0.01%	445
2025 Q1	$226K	Sell	1,765 -1	-0.1%	-$136	0.01%	383
2024 Q4	$233K	Sell	1,766 -529	-23%	-$74.4K	0.01%	338
2024 Q3	$334K	Sell	2,295 -618	-21%	-$89.4K	0.01%	310
2024 Q2	$400K	Buy	+2,913	New	+$389K	0.01%	303
2022 Q2	–	Sell	-1,785	Closed	-$232K	–	330
2022 Q1	$232K	Sell	1,785 -978	-35%	-$127K	0.01%	300
2021 Q4	$421K	Buy	+2,763	New	+$428K	0.03%	201
2014 Q4	–	Sell	-1,110	Closed	-$101K	–	294
2014 Q3	$101K	Buy	+1,110	New	+$97.4K	0.04%	178

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

One Capital Management's IBB Position: Q2 2026 in Review

One Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,356 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #492.

One Capital Management first reported a position in IBB in Q3 2014 and has held it in 12 quarters since. The position peaked at $421K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

One Capital Management held 1,356 shares of iShares Biotechnology ETF worth $229K as of Q2 2026.
One Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of One Capital Management's portfolio in Q2 2026, its #492 holding.
One Capital Management first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 12 quarters since.
One Capital Management's iShares Biotechnology ETF position peaked at $421K in Q4 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.